Ivi, inovio, and knih to partner with cepi in phase 1/2 clinical trial of inovio's covid-19 dna vaccine in south korea

Ivi, inovio, and knih to partner with cepi in phase 1/2 clinical trial of inovio's covid-19 dna vaccine in south korea.inovio pharmaceuticals - coalition for epidemic preparedness innovations (cepi) grants $6.9 million funding to co & international vaccine institute.inovio pharmaceuticals - ivi will conduct phase 1/2 clinical trial in parallel to co's phase 1 ino-4800 study currently underway in u.s..
INO Ratings Summary
INO Quant Ranking